Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human papillomavirus vaccines: challenges to implementation.

Suzanne M Garland

    Sexual Health
    |June 28, 2006
    PubMed
    Summary

    Prophylactic human papillomavirus (HPV) vaccines show promising results, potentially preventing 70% of cervical cancers. Effective vaccination programs require addressing vaccine accessibility, cost, and clear public and professional education on HPV.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Causative Human Papillomavirus (HPV) Genotypes of Anal Cancers in Australian Cisgender Women.

    Journal of medical virology·2026
    Same author

    Clinicopathologic characteristics and predictors of treatment uptake among patients with cervical cancer managed at Jimma University Medical Center, Southwest Ethiopia.

    BMC cancer·2026
    Same author

    Time to death and its determinants among cervical cancer patients in Tigray, Ethiopia: a retrospective follow up study.

    BMC cancer·2026
    Same author

    Immunogenicity of HPV Vaccine in a High-Risk and Understudied Group: Female Sex Workers.

    The Journal of infectious diseases·2026
    Same author

    Novel features of <i>Mycoplasma genitalium</i> genomes identified through Oxford Nanopore sequence analysis of isolates from Australia.

    Microbial genomics·2026
    Same author

    Gut microbiota composition in preterm infants with and without necrotizing enterocolitis: a systematic review and narrative synthesis.

    Access microbiology·2025

    Area of Science:

    • Immunology
    • Oncology
    • Public Health

    Background:

    • Clinical trials demonstrate high efficacy of prophylactic human papillomavirus (HPV) vaccines.
    • Widespread HPV vaccination coverage is projected to prevent 70% of cervical cancers and other anogenital diseases.

    Discussion:

    • Key considerations include gender inclusivity in vaccination, immune response durability, HPV type attribution, and vaccine cost-effectiveness.
    • Effective HPV vaccination strategies necessitate clear, consistent educational messaging for both the public and healthcare professionals.

    Key Insights:

    • HPV vaccines offer a significant public health intervention against HPV-related cancers.
    • Successful implementation hinges on addressing logistical and educational challenges.

    Outlook:

    • Continued research on vaccine effectiveness and long-term immune response is crucial.
    • Global accessibility and affordability of HPV vaccines are essential for maximizing disease prevention.

    Related Experiment Videos